Latham Group enters August with a notable insider vote of confidence — but the stock is still down 7% over the past month, and the Street remains divided on whether the pool manufacturer's recovery thesis has legs.
The insider signal is the clearest talking point this week. In May, both the CFO and the Chairman of the Board purchased shares in the open market at prices in the $4.84–$4.90 range, well below today's close of $5.70. Chairman James Cline put $242,000 to work across 50,000 shares on May 19, while CFO Oliver Gloe followed with a $73,745 purchase the next day. Net insider activity over the trailing 90 days comes to roughly 142,000 shares bought, worth about $800,000 — a meaningful signal from the two most senior figures in the company. Earlier sells in March were smaller, routine-looking transactions spread across mid-level executives and look more like compensation-related disposals than conviction moves against the stock.
Positioning in the lending market is relaxed rather than charged. Short interest has been easing — down 5% on the week to 3.6% of the free float — after climbing roughly 5% over the prior month. At that level, short interest is modest; it doesn't dominate the setup. Borrow availability is loose at 303%, meaning there are roughly three shares available for every one already borrowed, and borrowing costs are low at 0.63% annualised — barely changed and well within normal range. The ORTEX short score has drifted lower over the past two weeks, from 58.9 to 57.1, consistent with shorts trimming rather than adding. Options positioning has actually turned more bullish than usual: the put/call ratio has dropped to 0.018, its lowest reading of the past year and well below its 20-day average of 0.059, suggesting call-side activity is dominating what is admittedly a thin options market.
The Street picture is mixed, but recently the bias has been downward on targets. B of A Securities lowered its price target to $6.00 from $7.00 in April while keeping an Underperform rating — the current price has since moved toward that floor. Barclays trimmed to $7.00 from $8.00 around the same time, holding a neutral stance. Stifel is the bullish outlier, carrying a Buy rating with a $9.50 target after raising it in March. The mean analyst target of $8.16 implies roughly 43% upside from current levels, though the range of outcomes is wide. EPS momentum is constructive — the 90-day reading ranks in the 85th percentile — but the forward earnings yield multiple has been compressing, with the PE ratio down roughly 3.6 points over the past 30 days to around 21x as the stock has softened. The short score rank of 12 and days-to-cover rank of 8 suggest the stock screens as lightly shorted relative to its universe, which removes one potential headwind.
Ownership is heavily concentrated. Pamplona Capital Management holds 44% of shares outstanding, a position that has not changed recently. Wellington added 2.4 million shares in Q1, and a new entrant — ACK Asset Management — disclosed a full 5.16 million share position as of March 31, representing 4.4% of the company. Those are meaningful votes of confidence from active managers, though the stock is down from where most of those trades were likely executed. Peers have been mixed on the week: BC and PII each gained around 4–5% on Tuesday alone, while GOLF slipped 1.2% on the week and JAKK fell 2.3% — no clean read-through for SWIM from the broader leisure space.
The next scheduled earnings event is November 3, leaving the setup for now to be shaped by the insider buying narrative and whether the stock can close the gap between its current price and the analyst consensus — with the B of A floor at $6.00 the immediate level worth watching.
See the live data behind this article on ORTEX.
Open SWIM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
